Multiple Myeloma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
W
Recruiting
  • Multiple Myeloma
  • +2 more
  • New York, New York
    Weill Cornell Medicine - Multiple Myeloma Center
2021-11-18
Nov 18, 2021
T
Active, not recruiting
  • Multiple Myeloma
  • Odense, Denmark
    Odense University Hospital
2021-11-18
Nov 18, 2021
M
Recruiting
  • Multiple Myeloma
  • +2 more
  • Acupuncture
  • +2 more
  • New York, New York
  • +1 more
2021-11-18
Nov 18, 2021
N
Not yet recruiting
  • Multiple Myeloma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-11-18
Nov 18, 2021
G
Recruiting
  • Multiple Myeloma
  • Magrolimab
  • +4 more
  • Charlotte, North Carolina
    Levine Cancer Institute
2021-11-11
Nov 11, 2021
H
Active, not recruiting
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-18
Nov 18, 2021
M
Active, not recruiting
  • Multiple Myeloma
  • EGFRt/BCMA-41BBz CAR T cell
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-11-18
Nov 18, 2021
S
Recruiting
  • Multiple Myeloma
  • Carfilzomib, Lenalidomide, Dexamethasone, Belantamab Mafodotin
  • Charlotte, North Carolina
    Levine Cancer Institute
2021-11-17
Nov 17, 2021
S
Recruiting
  • Multiple Myeloma
  • Palo Alto, California
  • +10 more
2021-11-12
Nov 12, 2021
O
Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +104 more
2021-11-17
Nov 17, 2021
A
Enrolling by invitation
  • Chronic Lymphocytic Leukemia
  • +5 more
  • Tucson, Arizona
  • +51 more
2021-11-16
Nov 16, 2021
C
Not yet recruiting
  • Multiple Myeloma
  • Aarhus, Denmark
  • +5 more
2021-11-05
Nov 5, 2021
M
Active, not recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
2021-11-16
Nov 16, 2021
T
Recruiting
  • Multiple Myeloma
  • Wolverhampton, United Kingdom
    The Royal Wolverhampton NHS Trust
2021-11-09
Nov 9, 2021
N
Recruiting
  • Multiple Myeloma
  • PHE885
  • Chicago, Illinois
  • +3 more
2021-11-15
Nov 15, 2021
H
Active, not recruiting
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021
M
Active, not recruiting
  • Multiple Myeloma
  • High Risk Smoldering Multiple Myeloma
  • Basking Ridge, New Jersey
  • +5 more
2021-11-15
Nov 15, 2021
H
Suspended
  • Multiple Myeloma
  • Survivin Vaccine
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021
M
Completed
  • Multiple Myeloma
  • MOR03087 phase 1 dose escalation
  • +4 more
  • Vienna, Austria
  • +9 more
2021-11-12
Nov 12, 2021
A
Terminated
  • Multiple Myeloma
  • Waldenstrom Macroglobulinemia
  • Scottsdale, Arizona
  • +18 more
2021-11-15
Nov 15, 2021
I
Active, not recruiting
  • Lung Cancer
  • +10 more
  • Birmingham, Alabama
  • +19 more
2021-11-11
Nov 11, 2021
U
Active, not recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +2 more
2021-11-12
Nov 12, 2021